MET and hepatocellular carcinoma: Recent findings suggest it suppresses HCC by regulating the signaling pathways of the hepatocyte growth factor (HGF)/mesenchymal-epithelial transition factor (MET) and the Wnt/Dvl2/β-catenin signaling.